Skip to main content
NIH funding notice PAR-20-180

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

Closed on January 7, 2024.

Posted
April 30, 2020
Close date
January 7, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,385,850 in first-year total cost, median $692,925.

Most frequent study sections

  1. Biobehavioral Medicine and Health Outcomes Study Section[BMHO]1
  2. Special Emphasis Panel[ZRG1 HSS-B (90)]1

Most frequent institutions

  1. MIRIAM HOSPITAL1
  2. UNIVERSITY OF UTAH1
Competing awards under PAR-20-180 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024A Novel mHealth Intervention to Improve Outcomes of Children with Medical Complexity1R01NR020784-01A1NKOY, FLORY LUNIVERSITY OF UTAH, UT$631,544ZRG1
2022Targeting cognitive function and interoceptive awareness to improve self-management in patients with co-morbid heart failure and cognitive impairment.1R01AG076438-01SALMOIRAGO-BLOTCHER, ELENAMIRIAM HOSPITAL, RI$754,306BMHO

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.